On Tuesday, Riyadh — Saudi Arabia’s Ministry of Industry announced the signing of a memorandum of understanding (MoU) with the Pfizer Foundation for the manufacture of viral and genetic vaccines in the Kingdom.
The pact inked on the sidelines of the first day of the Riyadh Global Medical Biotechnology Summit 2021 (RGMBS) was conducted under the auspices of Crown Prince Muhammad Bin Salman. The honorable Minister of the National Guard, Prince Abdullah Bin Bandar, inaugurated the virtual event.
The tripartite MoU, signed between the Pfizer Foundation, the Ministry of Industry, the King Abdullah International Medical Research Center (KAIMRC), will build the foundations for the manufacture of viral and genetic vaccines in Saudi Arabia.
Eminent international speakers, pioneers, and leaders of biotech companies at international levels addressed the summit discussing the role of biotechnology in developing vaccines, medicines, and genetic treatments.
The summit also discussed models and opportunities for the development of biotechnologies and academic and industrial collaborations.
KAIMRC, as a National Guard Health Affairs subsidiary, has evolved to transform lab research results into products that improve the quality of life and train researchers within the healthcare community.
